PEGylation and Biodistribution of an anti-MUC1 Aptamer in MCF-7 Tumor-Bearing Mice

被引：61

作者：

Da Pieve, Chiara ^{[1
]}

Blackshaw, Elaine ^{[2
]}

Missailidis, Sotiris ^{[1
]}

Perkins, Alan C. ^{[2
]}

机构：

[1] Open Univ, Dept Chem & Analyt Sci, Milton Keynes MK7 6AA, Bucks, England

[2] Univ Nottingham, Sch Clin Sci, Acad Med Phys, Nottingham NG7 2UH, England

来源：

BIOCONJUGATE CHEMISTRY | 2012年 / 23卷 / 07期

关键词：

DNA APTAMERS; DESIGN; CONJUGATION; TC-99M; MARKER;

D O I：

10.1021/bc300128r

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Aptamers are characterized by a rapid renal clearance leading to a short in vivo circulating half-life. In order to use aptamers as anticancer therapeutic agents, their exposure time to the tumor has to be enhanced via increasing residency in the bloodstream. A way to achieve this goal is by conjugating the aptamer to poly(ethylene glycol) (PEG). Herein, we present the conjugation of a bifunctionalized anti-MUC1 aptamer (NH2-AptA-SR) with the Tc-99m coordinating moiety MAG2 and either a conventional branched PEG or the comb-shaped PolyPEG via a two-step synthesis. The isolated products were radiolabeled with Tc-99m and their biodistribution and tumor-targeting properties in MCF-7 tumor bearing mice were analyzed and compared.

引用

页码：1377 / 1381

页数：5

共 21 条

[1] Polyethylene glycol-conjugated pharmaceutical proteins
Bailon, P
Berthold, W
[J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08): : 352 - 356
[2] Solution structure of a truncated anti-MUC1 DNA aptamer determined by mesoscale modeling and NMR
Baouendi, Meriem
Cognet, Jean A. H.
Ferreira, Catia S. M.
Missailidis, Sotiris
Coutant, Jerome
Piotto, Martial
Hantz, Edith
du Penhoat, Catherine Herve
[J]. FEBS JOURNAL, 2012, 279 (03) : 479 - 490
[3] Conjugation to polyethylene glycol polymer promotes aptamer biodistribution to healthy and inflamed tissues
Boomer, RM
Lewis, SD
Healy, JM
Kurz, M
Wilson, C
McCauley, TG
[J]. OLIGONUCLEOTIDES, 2005, 15 (03) : 183 - 195
[4] Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to Anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer
Borbas, K. Eszter
Ferreira, Catia S. M.
Perkins, Alan
Bruce, James I.
Missailidis, Sotiris
[J]. BIOCONJUGATE CHEMISTRY, 2007, 18 (04) : 1205 - 1212
[5] Nucleic acid aptamers in cancer medicine
Cerchia, L
Hamm, J
Libri, D
Tavitian, B
de Franciscis, V
[J]. FEBS LETTERS, 2002, 528 (1-3): : 12 - 16
[6] Cosmi B, 2009, CURR OPIN MOL THER, V11, P322
[7] Modification of Thiol Functionalized Aptamers by Conjugation of Synthetic Polymers
Da Pieve, Chiara
Williams, Paul
Haddleton, David M.
Palmer, Richard M. J.
Missailidis, Sotiris
[J]. BIOCONJUGATE CHEMISTRY, 2010, 21 (01) : 169 - 174
[8] Anti-MUC1 aptamers: radiolabelling with 99mTc and biodistribution in MCF-7 tumour-bearing mice
Da Pieve, Chiara
Perkins, Alan C.
Missailidis, Sotiris
[J]. NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (06) : 703 - 710
[9] The dawning era of polymer therapeutics
Duncan, R
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) : 347 - 360
[10] DNA aptamers against the MUC1 tumour marker: design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours
Ferreira, C. S. M.
Papamichael, K.
Guilbault, G.
Schwarzacher, T.
Gariepy, J.
Missailidis, S.
[J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 390 (04) : 1039 - 1050

← 1 2 3 →